Yunfu Deng
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition to delay emergence of acquired resistance of lung cancer to osimertinib.
Journal: Cancer letters
Published: May 14, 2025
Correction to: Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1.
Journal: Cancer gene therapy
Published: May 10, 2022
Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1.
Journal: Cancer gene therapy
Published: February 01, 2022
Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both.
Journal: Oncogene
Published: August 16, 2021
Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors.
Journal: Molecular cancer research : MCR
Published: February 24, 2021
Identification of tumor microenvironment-based genes associated with acquired resistance to EGFR Tyrosine Kinase Inhibitor in Lung Adenocarcinoma.
Journal: Journal of Cancer
Published: December 10, 2020
The combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients with resected breast cancer.
Journal: Medicine
Published: May 03, 2020
Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Journal: Thoracic cancer
Published: November 27, 2019
Last Updated: 09/26/2026